Analysts expect Ptc Therapeutics, Inc. to report revenue of 346.09 M for Q4 26, against a range of 324.28 M to 367.90 M. The most recent reported quarter, Q3 26, came in at 357.81 M, a 21.2% beat against the 295.22 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 213.17 M | 1.18 B | 178.88 M | 211.01 M | 164.68 M | 272.55 M | 360.52 M | 357.81 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 238.65 M | 193.45 M | 175.92 M | 170.89 M | 317.30 M | 228.13 M | 344.27 M | 307.78 M | 367.90 M | 305.01 M | 335.52 M | 357.41 M | 391.52 M | 496.53 M | 396.21 M | 412.56 M | |||||||||
| Low Estimate | 212.52 M | 165.55 M | 148.91 M | 153.09 M | 269.18 M | 192.04 M | 284.08 M | 282.66 M | 324.28 M | 281.59 M | 312.43 M | 295.60 M | 337.75 M | 431.19 M | 336.87 M | 340.47 M | |||||||||
| Consensus Estimate | 225.59 M | 179.50 M | 162.42 M | 161.99 M | 293.24 M | 210.09 M | 314.18 M | 295.22 M | 346.09 M | 293.30 M | 323.98 M | 326.51 M | 364.64 M | 463.86 M | 366.54 M | 376.51 M |
Analysts expect Ptc Therapeutics, Inc. to report earnings per share of 0.36 for Q4 26, against a range of 0.33 to 0.39. The most recent reported quarter, Q3 26, came in at -0.62, a 542.9% miss against the 0.14 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.85 | 10.04 | -0.83 | 0.20 | -1.67 | -0.03 | 0.92 | -0.62 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.46 | -0.98 | -0.90 | -1.10 | 0.11 | -0.42 | 0.26 | 0.15 | 0.39 | 0.53 | 0.62 | 0.58 | 0.62 | 2.10 | 0.39 | 0.94 | |||||||||
| Low Estimate | -0.54 | -1.16 | -1.06 | -1.30 | 0.09 | -0.46 | 0.24 | 0.13 | 0.33 | 0.45 | 0.52 | 0.54 | 0.58 | 1.88 | 0.37 | 0.86 | |||||||||
| Consensus Estimate | -0.50 | -1.07 | -0.98 | -1.20 | 0.10 | -0.44 | 0.25 | 0.14 | 0.36 | 0.49 | 0.57 | 0.56 | 0.60 | 1.99 | 0.38 | 0.90 |
Pull Wall Street consensus for Ptc Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PTCT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PTCT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PTCT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();